8.00 – 8.40: Registration
8.45 – 8.55: Welcome Address
9.00 – 9.45: Session 1 – Impact of environmental and biological factors on diseases course
Chair: TBC
9.00 – 9.15: Neural and immune biomarkers and course of MOGAD – Romain MARIGNIER (Lyon, FR)
9.15 – 9.30: Mediators of the link between socioeconomic status and disability progression in MS – Emmanuelle LERAY (Rennes, FR)
9.30 – 9.45: Impact of MS on individuals’ personal identity, memories and projections into the future – Alexandra ERNST (Paris, FR)
9.50 – 10.30: Session 2: What new about MS lesions imaging
Chair: TBD
9.50 – 10.05: Update on chronic active lesion and the central vein sign – Back to the MRI Workshop 2025 – TBD
10.05 – 10.20: Motor tract damage and relationship to functional disability in people with multiple sclerosis – Anne KERBRAT (Rennes, FR)
10.20 – 10.30 : FUSION4MS consortium – Adil MAAROUF (Marseille, FR)
10.30 – 11.00: COFFEE BREAK
11.00 – 12.00: Session 3 – 6 Short oral communications
Chair: Pierre-Olivier COURAUD (Paris, FR)
12.00 – 12.45: Session 4 – Keynote lecture
Chair: TBC
Immunological mechanisms in MS – present and future therapeutic impacts – Frauke ZIPP (Mainz, GER)
12.45 – 14.30: LUNCH BREAK & POSTER SESSION
14.30 – 15.30: Session 4: Role and interaction of the immune cells of the CNS
Chair: TBC
14.30 – 15.00: Cross-talk between follicular T cells and B cells in Multiple Sclerosis: exploring an intimate relationship – Laure MICHEL (Rennes, FR) & Nicolas FAZILLEAU (Toulouse, FR)
15.00 – 15.15: Identifying molecular targets to manipulate monocytes as a therapeutic strategy in multiple sclerosis – Elodie SEGURA (Paris, FR)
15.30 – 15.45: Therapeutic effect of IL-10-producing B cells in chronic autoimmune disease of the central nervous system: roles of microglia, macrophages, and astrocytes – Simon FILLATREAU (Paris, FR)
15.30 – 16.15: Session 6: Towards new therapeutic targets?
Chair: TBC
15.30 – 15.45: Pharmacogenomic screening identifies and repurposes leucovorin and dyclonine as pro-oligodendrogenic compounds in brain repair – Carlos PARRAS (Paris, FR)
15.45 – 16.00: Usage of the molecule APRIL to combine anti-inflammatory and proregenerative actions in multiple sclerosis – Bertrand HUARD (Grenoble, FR)
16.00 – 16.15: Function and therapeutic targeting of the NF-kB2 transcription factor in experimental autoimmune encephalomyelitis – Yenkel GRINBERG-BLEYER (Lyon, FR)
16.15: Prizes of the best poster & the best short oral communication
Chairs: President and Vice-presidents of the scientific committee
16.30: End of the meeting
Organizing committee : Scientific Committee of ARSEP Foundation
Deadline for abstract submission (strongly recommended for those who have been granted): May 5, 2025
Deadline for registration (free but mandatory): June 6, 2024
Travel grants available for young researchers:
Information & Registration (online) : https://www.arsep.org/fr/337.html
